American Oncology Network Inc Receivables Turnover Ratio (AONC), from the fourth quarter 2024 to the fourth quarter 2023 current and historic results, rankings and more - CSIMarket
CSIMarket
 


American Oncology Network Inc   (AONC)
 

American Oncology Network Inc Accounts Receivables Turnover Ratio from the fourth quarter 2024 to the fourth quarter 2023

Quarterly Results, Trends, Rankings, Statistics


American Oncology Network Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2024 to a ratio of 9.61, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the fourth quarter 2024. Average receivable collection period, for the American Oncology Network Inc in Dec 31 2024 quarter, has decreased to 38 days, compared to 41 days, in the Sep 30 2024 quarter.

If we take a look into Healthcare sector only one company was able to collect receivables faster. While total ranking has deteriorated relative to the period ending Dec 31 2024 from 11 to 37.

What is Receivable Turnover Ratio?
What is American Oncology Network Inc Selling?


What is Receivable Turnover Ratio?





AONC Receivables Turnover Ratio (Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
Y / Y Receivable Change 14.69 % 7.52 % - - -
Y / Y Revenue Change 51.42 % 39.84 % 37.79 % 19.95 % 7.92 %
Receivable Turnover Ratio (TTM) 9.61 9 8.4 10.54 15
AONC's Total Ranking # 37 # 11 # 910 # 0 # 0
Accounts Receivable average collection period days 38 41 43 35 24
Seq. Receivable Change -1.95 % 2.58 % 11.52 % 2.25 % -8.08 %
Seq. Revenue Change 4.38 % 8.36 % 19.11 % 12.39 % -3.6 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 0
Healthcare Sector # 2
Overall Market # 37

Receivable Turnover Ratio Statistics
High Average Low
5.45 4.89 4.1
(Sep 30 2024)   (Dec 31 2024)






Financial Statements
American Oncology Network Inc 's Accounts Receivable $ 187 Millions Visit AONC's Balance sheet
American Oncology Network Inc 's Sales TTM $ 1,759 Millions Visit AONC's Income Statement
Sources of AONC's Revenues Visit AONC's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AONC's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AONC's Growth Rates AONC's Roa AONC's Inventory Turnover Ratio AONC's Dividend Comparisons
AONC's Profitability Ratios AONC's Roi AONC's Asset Turnover Ratio AONC's Dividend Growth
AONC's Valuation Ratios AONC's Roe AONC's Financial Strength Ratios AONC's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2024, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2024 Receivable at quarter ending Dec 31 2024
Evotec Se  25.61 $ 892.603  Millions$ 34.857  Millions
Pulmatrix Inc   25.43 $ 7.806  Millions$ 0.307  Millions
Nutriband Inc   25.42 $ 2.140  Millions$ 0.084  Millions
Atara Biotherapeutics Inc   25.32 $ 259.990  Millions$ 10.268  Millions
Cytomx Therapeutics Inc   24.65 $ 138.103  Millions$ 5.602  Millions
Euda Health Holdings Limited  24.56 $ 3.762  Millions$ 0.153  Millions
Adaptimmune Therapeutics Plc  24.06 $ 178.032  Millions$ 7.399  Millions
Sonida Senior Living Inc   23.81 $ 304.326  Millions$ 12.783  Millions
Ethema Health Corporation   23.77 $ 6.017  Millions$ 0.253  Millions
Arvinas Inc   23.11 $ 263.400  Millions$ 11.400  Millions
Inventiva S a   22.85 $ 26.794  Millions$ 1.173  Millions
Macrogenics Inc   22.66 $ 149.962  Millions$ 6.617  Millions
Neuroone Medical Technologies Corp  22.59 $ 6.455  Millions$ 0.286  Millions
Bespoke Extracts Inc  21.73 $ 1.117  Millions$ 0.051  Millions
Innovative Eyewear Inc   21.59 $ 1.636  Millions$ 0.076  Millions
Marpai Inc  21.43 $ 27.977  Millions$ 1.305  Millions
Valneva Se  21.09 $ 189.928  Millions$ 9.006  Millions
Legend Biotech Corporation  20.70 $ 627.241  Millions$ 30.300  Millions
Neuraxis Inc   20.09 $ 2.686  Millions$ 0.134  Millions
Ontrak Inc   19.43 $ 10.824  Millions$ 0.557  Millions
Precipio inc   19.34 $ 18.532  Millions$ 0.958  Millions
Valion Bio Inc   18.57 $ 0.780  Millions$ 0.042  Millions
Lakeshore Biopharma Co Ltd  17.92 $ 80.820  Millions$ 4.511  Millions
Silence Therapeutics Plc  17.91 $ 43.258  Millions$ 2.416  Millions
Talkspace Inc   17.86 $ 186.836  Millions$ 10.459  Millions
Vireo Growth Inc.  17.37 $ 99.384  Millions$ 5.721  Millions
Innovage Holding Corp   16.74 $ 806.613  Millions$ 48.177  Millions
Generation Bio Co   16.67 $ 19.892  Millions$ 1.193  Millions
Kiniksa Pharmaceuticals International Plc  16.43 $ 423.239  Millions$ 25.764  Millions
Milestone Scientific Inc   16.26 $ 8.435  Millions$ 0.519  Millions

Date modified: 2026-09-08T15:11:28+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.